New Lung Model Reveals RSV Immune Response, Points to Better Treatments
Researchers used pediatric airway cells, blood vessel cells, and neutrophils to build an in vitro model of infant lungs that allowed them to investigate why respiratory syncytial virus makes infants…
Read the full articleYou might also wanna read
Animal-free lung model unlocks better treatments for RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure babies get the best poss
New clues raise hopes for better treatment of RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies get the best poss
The Math Behind RSV Protection: What Expanding Infant Coverage Actually Achieves
A new mathematical model shows that expanding RSV antibody prophylaxis to more infants could prevent infections across all age groups—but wo
Clinical trials seek way to prevent RSV, a common infection in infants and toddlers
Interview with pediatric infectious disease specialist Joe Domachowske, MD
RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases
Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requir
Medication shows promise in preventing RSV, a sometimes deadly infection, in babies
Interview with pediatric infectious disease specialist Joe Domachowske, MD
Comments
Sign in to join the conversation.
No comments yet. Be the first.